Reappraisal of Antihypertensive Medicine Doxazosin and Carvedilol as a Potential Therapeutic for Hepatic Fibrosis

Gut Liver. 2016 Jan;10(1):10-1. doi: 10.5009/gnl15576.

Author

Yong-Han Paik^{1

2}

Affiliations

¹ Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine,Seoul, Korea.
² Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antihypertensive Agents*
Doxazosin*
Humans
Liver Cirrhosis

Substances

Antihypertensive Agents
Doxazosin